Rothschild Investment LLC’s Cidara Therapeutics CDTX Stock Holding History

Rothschild Investment LLC’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-26	Closed	-$5.74K	–	3618
2025 Q4	$5.74K	Buy	26 +11	+73%	+$1.78K	﹤0.01%	1819
2025 Q3	$1.44K	Buy	+15	New	+$957	﹤0.01%	2423

Rothschild Investment LLC's CDTX Position: Q1 2026 in Review

Rothschild Investment LLC sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 26 shares — an estimated $5.74K sold.

Rothschild Investment LLC first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $5.74K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Rothschild Investment LLC reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Rothschild Investment LLC sold 26 Cidara Therapeutics shares in Q1 2026, an estimated $5.74K.
Rothschild Investment LLC first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
Rothschild Investment LLC's Cidara Therapeutics position peaked at $5.74K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.